To require counterfeit-resistant technologies for prescription drugs.
Sen. David Vitter (R-LA)Text
Submitted
Plain text for this version is not available yet.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Considered by Senate. (consideration: CR S5682)
May 8, 2007
View full timeline
Considered by Senate. (consideration: CR S5682)
May 8, 2007
Proposed amendment SA 983 withdrawn in Senate.
May 8, 2007
Considered by Senate. (consideration: CR S5634)
May 7, 2007
Considered by Senate. (consideration: CR S5526)
May 3, 2007
Senate amendment proposed (on the floor): Amendment SA 983 proposed by Senator Vitter.(consideration: CR S5482-5485; text: CR S5482-5483)
May 2, 2007
Amendment SA 983 proposed by Senator Vitter. (consideration: CR S5482-5485; text: CR S5482-5483) To require counterfeit-resistant technologies for prescription drugs.
May 2, 2007
Senate amendment submitted
May 1, 2007